tiprankstipranks
Universal Health (MX:UHS)
:UHS
Mexico Market
UHS
Universal Health
RESEARCH TOOLSreports

Universal Health (UHS) Ratios

0 Followers

Universal Health Ratios

MX:UHS's free cash flow for Q2 2026 was $0.91. For the 2026 fiscal year, MX:UHS's free cash flow was decreased by $ and operating cash flow was $0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.12 1.05 1.27 1.40 1.33
Quick Ratio
 1.04 0.98 1.17 1.29 1.21
Cash Ratio
 0.04 0.04 0.06 0.06 0.05
Solvency Ratio
 0.26 0.25 0.22 0.17 0.17
Operating Cash Flow Ratio
 0.55 0.58 0.94 0.63 0.52
Short-Term Operating Cash Flow Coverage
 2.33 2.27 51.60 10.01 12.23
Net Current Asset Value
$ -4.60B$ -5.14B$ -4.89B$ -4.95B$ -4.99B
Leverage Ratios
Debt-to-Assets Ratio
 0.33 0.35 0.34 0.38 0.39
Debt-to-Equity Ratio
 0.70 0.76 0.74 0.87 0.89
Debt-to-Capital Ratio
 0.41 0.43 0.43 0.47 0.47
Long-Term Debt-to-Capital Ratio
 0.35 0.37 0.40 0.44 0.44
Financial Leverage Ratio
 2.12 2.19 2.17 2.27 2.28
Debt Service Coverage Ratio
 2.53 2.33 8.48 4.46 6.54
Interest Coverage Ratio
 13.22 12.68 8.97 5.67 7.89
Debt to Market Cap
 0.47 0.37 0.38 0.46 0.47
Interest Debt Per Share
 90.84 89.09 77.28 80.41 73.83
Net Debt to EBITDA
 1.82 1.96 2.13 3.07 3.28
Profitability Margins
Gross Profit Margin
90.69%90.45%89.97%89.27%89.00%
EBIT Margin
12.03%12.23%10.62%8.00%7.41%
EBITDA Margin
15.57%15.80%14.31%11.98%11.75%
Operating Profit Margin
11.36%11.48%10.63%8.23%7.49%
Pretax Profit Margin
11.19%11.36%9.46%6.58%6.46%
Net Profit Margin
8.42%8.57%7.22%5.03%5.04%
Continuous Operations Profit Margin
8.56%8.70%7.35%5.04%4.90%
Net Income Per EBT
75.30%75.49%76.24%76.33%77.99%
EBT Per EBIT
98.45%98.90%89.07%80.01%86.32%
Return on Assets (ROA)
9.58%9.33%7.89%5.14%5.01%
Return on Equity (ROE)
20.66%20.46%17.13%11.67%11.41%
Return on Capital Employed (ROCE)
16.29%15.68%13.72%9.83%8.67%
Return on Invested Capital (ROIC)
11.68%11.29%10.55%7.40%6.49%
Return on Tangible Assets
12.77%12.52%10.92%7.15%7.05%
Earnings Yield
15.08%10.74%9.56%6.79%6.56%
Efficiency Ratios
Receivables Turnover
 6.47 6.67 7.27 6.38 6.64
Payables Turnover
 0.69 2.21 2.51 2.50 2.32
Inventory Turnover
 7.21 7.15 7.19 7.06 6.75
Fixed Asset Turnover
 2.41 2.35 2.26 2.18 2.10
Asset Turnover
 1.14 1.09 1.09 1.02 0.99
Working Capital Turnover Ratio
 56.85 44.86 22.55 20.10 29.70
Cash Conversion Cycle
 -423.21 -59.27 -44.27 -37.33 -48.54
Days of Sales Outstanding
 56.44 54.70 50.22 57.20 54.96
Days of Inventory Outstanding
 50.64 51.07 50.79 51.67 54.10
Days of Payables Outstanding
 530.29 165.04 145.28 146.20 157.60
Operating Cycle
 107.09 105.77 101.01 108.87 109.06
Cash Flow Ratios
Operating Cash Flow Per Share
 30.19 29.32 31.06 18.29 13.62
Free Cash Flow Per Share
 13.86 13.36 16.88 7.57 3.58
CapEx Per Share
 16.32 15.97 14.18 10.72 10.04
Free Cash Flow to Operating Cash Flow
 0.46 0.46 0.54 0.41 0.26
Dividend Paid and CapEx Coverage Ratio
 1.76 1.75 2.07 1.59 1.26
Capital Expenditure Coverage Ratio
 1.85 1.84 2.19 1.71 1.36
Operating Cash Flow Coverage Ratio
 0.34 0.34 0.42 0.24 0.19
Operating Cash Flow to Sales Ratio
 0.10 0.11 0.13 0.09 0.07
Free Cash Flow Yield
8.05%6.13%9.41%4.97%2.54%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 6.88 9.31 10.46 14.72 15.25
Price-to-Sales (P/S) Ratio
 0.57 0.80 0.75 0.74 0.77
Price-to-Book (P/B) Ratio
 1.35 1.91 1.79 1.72 1.74
Price-to-Free Cash Flow (P/FCF) Ratio
 12.42 16.32 10.63 20.14 39.32
Price-to-Operating Cash Flow Ratio
 5.62 7.44 5.78 8.34 10.34
Price-to-Earnings Growth (PEG) Ratio
 0.25 0.26 0.16 1.21 -0.66
Price-to-Fair Value
 1.35 1.91 1.79 1.72 1.74
Enterprise Value Multiple
 5.46 7.01 7.40 9.24 9.82
Enterprise Value
 15.39B 19.23B 16.77B 15.81B 15.47B
EV to EBITDA
 5.46 7.01 7.40 9.24 9.82
EV to Sales
 0.85 1.11 1.06 1.11 1.15
EV to Free Cash Flow
 18.62 22.65 14.93 30.14 59.04
EV to Operating Cash Flow
 8.55 10.32 8.11 12.47 15.53
Tangible Book Value Per Share
 61.59 52.58 41.37 32.74 28.18
Shareholders’ Equity Per Share
 125.98 114.43 100.16 88.70 80.97
Tax and Other Ratios
Effective Tax Rate
 0.24 0.23 0.22 0.24 0.24
Revenue Per Share
 303.72 273.11 237.82 206.03 183.26
Net Income Per Share
 25.59 23.42 17.16 10.35 9.24
Tax Burden
 0.75 0.75 0.76 0.76 0.78
Interest Burden
 0.93 0.93 0.89 0.82 0.87
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.47 0.47 0.48 0.51 0.51
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 1.18 1.23 1.78 1.77 1.52
Currency in USD